TIGR® Matrix Surgical Mesh – Exhibited ahead of anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium

To mark the occasion, a special presentation has been organized on Wednesday May 11^th 2011 at the Zebrastraat venue in Ghent (http://www.novusscientific.com/events/), featuring renowned surgeons; Dr. Frederik Berrevoet, Ghent University Hospital, who will lecture on “From polypropylene to TIGR^® Matrix: towards the ‘ideal’ mesh” and Dr. Bruce Ramshaw, Halifax Health Medical Center, Daytona, FL, who will lecture on “Permanent mesh complications: How TIGR^® Matrix can help”. Henrik Magnusson, co-inventor of TIGR^® Matrix will deliver a lecture on the design and properties of long-term resorbable synthetic mesh and answer questions from the audience on how this new class of 100% resorbable synthetic mesh is filling an important gap between biologics and permanent synthetics.

“EHS 2011 marks an important milestone for TIGR^® Matrix and for Novus Scientific with presentation of the preliminary one year data from the First in Man clinical study. In this past year we have seen the growing acceptance by many surgeons of TIGR^® Matrix as a new approach to soft tissue repair. With the anticipated approval of the CE Mark, we are excited to be able to offer TIGR^® Matrix to leading surgeons and hospitals across Europe in the not too distant future” said Thomas Engström, CEO & President of Novus Scientific

“We look forward to establishing a presence in Europe and to introducing TIGR^® Matrix to the leading hernia centers once we attain the anticipated CE Mark. We have a major multicenter randomized controlled study planned with key opinion leaders and are very encouraged by the amount of attention TIGR^® Matrix is receiving ” said Tom Haeleydt, responsible for Sales & Marketing EMEA

TIGR^® Matrix is the World’s 1st Long-Term Resorbable Synthetic Mesh. US FDA cleared TIGR^® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists in February 2010.